Acta Med. 2000, 43: 23-27
https://doi.org/10.14712/18059694.2019.113
Changes of the Serum Antibiotic Levels During Open Heart Surgery (ceftazidim, ciprofloxacin, clindamycin)
References
1. Eur J Cardio-Thorac Surg 1997; 12:443-9.
< PE, Bernardo JE, Eugénio L, Ferrao de Oliveira J, Antunes MJ. Mediastinitis after aorto-coronary bypass surgery. https://doi.org/10.1016/S1010-7940(97)00179-6>
2. Eur J Cardio-Thorac Surg 1999; 15:45-50.
< J, Harris JM, Cullinan P, Gaya H, Pepper JR. A prospective study of wound infection in coronary artery surgery. https://doi.org/10.1016/S1010-7940(98)00255-3>
3. Clin Pharmacokinetics 1989; 17:10-26.
< WA, Herregods LL, Mortier EP, Bogaert MG. Cardiopulmonary bypass and the pharmacokinetics of drugs. An update. https://doi.org/10.2165/00003088-198917010-00002>
4. Eur J Cardio-Thorac Surg 1999; 15:365-9.
< AR, Yang L, Kay PH, Saleh M, Cooper GJ. A biochemical study of median sternotomy closure techniques. https://doi.org/10.1016/S1010-7940(99)00014-7>
5. Ann Thorac Surg 1998; 65:41-7.
< A, Yonan NA, Hassan R et al. Treatment of Mediastinitis: Early Modified Robicsek Closure and Pectoralis Major Advancement Flaps. https://doi.org/10.1016/S0003-4975(97)01063-1>
6. J Thorac Cardiovasc Surg 1969; 57:757-63.
F, Cluff L, Sabiston D, Seidl L, Smith J, Thoburn R. A study of antibiotic prophylaxis in cardiac surgery.
7. J Thorac Cardiovasc Surg 1979; 78:908-13.
I, Baker C, McKee D. The value of prophylactic antibiotics in aorta-coronary bypass operations.
8. Wis Med J 1963; 62:302-15.
JE, Dale AJ, McGoon DC. Bacterial endocarditis and endarteritis following cardiac operations.
9. N Engl J Med 1968; 278:117-23.
< J, Schaffner W, Collins H, Battersby E, Koenig M. Infection After cardiovascular surgery. https://doi.org/10.1056/NEJM196801182780301>
10. Ann Thorac Surg 1985; 40:214-21.
< EA, Culliford AT, Krieger KH et al. A survey of 77 major infections complications of median sternotomy: a review of 7949 consecutive operative procedures. https://doi.org/10.1016/S0003-4975(10)60030-6>
11. J Antimicrob Chemother 1995; 35:649-55.
< RM, Wilson APR, Hichens M et al. Clearance of gentamicin during cardiac surgery. https://doi.org/10.1093/jac/35.5.649>
12. Ann Thorac Surg 1992; 53:301-5.
< W, Lazenby WD, Zelano JA, Isom WO, Krieger KH. Effects of shaving methods and intraoperative irrigation on supperative mediastinitis after bypass operations. https://doi.org/10.1016/0003-4975(92)91337-9>
13. Chest 1997; 112:666-75.
< MH, Sharpless L, Vlastnik J, Pasque Ch, Murphy D, Fraser V. The Impact of Nosocomial Infections on Patient Outcome Following Cardiac Surgery. https://doi.org/10.1378/chest.112.3.666>
14. J Thorac Cardiovasc Surg 1992; 104:590-9.
B, Woods M. Antibiotic prophylaxis for cardiothoracic operations.
15. Perfusion 1992; 7:115-7.
< V, Manďák J, Lonská V, Rozsíval V, Marková D, Kubíček J. Serum oxacilin and cephazolin levels during cardiopulmonary bypass. https://doi.org/10.1177/026765919200700206>
16. Acta Medica (Hradec Králové) Suppl 1999; 42:57-9.
V, Dominik J, Lonská V et al. Kinetika ceftazidimu při profylaktické aplikaci u kardiopulmonálního bypassu.
17. Ann Thorac Surg 1990; 49:179-87.
< FD, Lytle BW, Cosgrove DM et al. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity and cost of care. https://doi.org/10.1016/0003-4975(90)90136-T>
18. J Cardiothorac Vasc Anesth 1997; 11:565-70.
< T, Sablotzki A, Welters I, Wagner RM, Zickman B, Gronau S. Concentration of cefamandole in plasma and tissues of patients undergoing cardiac surgery: the influence of different cefamandole dosage. https://doi.org/10.1016/S1053-0770(97)90005-7>
19. J Antimicrob Chemother 1997; 39:229-33.
< PA, Merlo F, Fabbri A, Padrini R. Teicoplanin concentrations in serum, pericardium, pericardial fluid and thoracic wall fat in patients undergoing cardiopulmonary bypass surgery. https://doi.org/10.1093/jac/39.2.229>
20. Int J Clin Pharmacology Research 1995; 15:23-5.
PA, Merlo F, Campanile F, Padrini R. Effects of cardiopulmonary bypass on teicoplanin serum disposition.
21. J Thorac Cardivasc Surg 1997; 114:162-8.
< U, Vogt M, Vogt P, Genoni M, Künzli A, Turina MI. Cardiac surgery in a high-risk group of patients: Is prolonged postoperative antibiotic prophylaxis effective? https://doi.org/10.1016/S0022-5223(97)70140-5>
22. Ann Thorac Surg 1996; 61:1030–6.
< RM, Wright JE. Postoperative mediastinitis: classification and management. https://doi.org/10.1016/0003-4975(95)01035-1>
23. Ann Int Med 1982; 97:309-17.
< RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. https://doi.org/10.7326/0003-4819-97-3-309>
24. J Antimicrob Chemother 1988; 21:201-12.
< APR, Taylor B, Treasure T et al. Antibiotic prophalaxis in cardiac surgery: serum and tussue levels of teicoplanin, flucloxacilin and tobramycin. https://doi.org/10.1093/jac/21.2.201>
25. J Antimicrob Chemother 1988; 21:213-23.
< APR, Treasure T, Gruneberg RN, Sturridge MF, Ross DN. Antibiotic prophylaxis in cardiac surgery: a prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacilin and tobramycin. https://doi.org/10.1093/jac/21.2.213>
26. J Antimicrob Chemother 1988; 21:522-4.
< APR. Antibiotic prophylaxis in cardiac surgery. https://doi.org/10.1093/jac/21.5.522>